2 chapters across the catalog
President Donald Trump announced a deal with Pfizer to lower drug prices and launch a new government website, TrumpRx.gov, in 2026. The deal includes a three-year tariff grace period for Pfizer in exchange for investing in the U.S. and matching international drug prices.
Vaccine Commercialization, Pfizer and Moderna Price Hikes
As the federal government stops purchasing COVID-19 vaccines in bulk, Pfizer and Moderna plan to raise prices to a range of $110 to $130 per dose on the open market. This represents a significant increase from the $26 per dose previously paid by the government. Jennifer Cates of the Kaiser Family Foundation notes that while insured individuals may not pay out-of-pocket, the costs will likely lead to higher insurance premiums.
